Smithfield Trust’s Jazz Pharmaceuticals JAZZ Stock Holding History

Smithfield Trust’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-43	Closed	-$4K	–	1068
2020 Q1	$4K	Buy	+43	New	+$5.56K	﹤0.01%	809
2017 Q1	–	Sell	-62	Closed	-$7K	–	797
2016 Q4	$7K	Hold	62	–	–	﹤0.01%	714
2016 Q3	$8K	Hold	62	–	–	﹤0.01%	723
2016 Q2	$9K	Hold	62	–	–	﹤0.01%	695
2016 Q1	$8K	Buy	+62	New	+$7.72K	﹤0.01%	712
2015 Q1	–	Sell	-140	Closed	-$23K	–	804
2014 Q4	$23K	Hold	140	–	–	﹤0.01%	609
2014 Q3	$22K	Hold	140	–	–	﹤0.01%	626
2014 Q2	$21K	Sell	140 -30	-18%	-$4.16K	﹤0.01%	647
2014 Q1	$24K	Sell	170 -40	-19%	-$6.02K	﹤0.01%	615
2013 Q4	$27K	Sell	210 -70	-25%	-$7.24K	0.01%	585
2013 Q3	$26K	Sell	280 -30	-10%	-$2.42K	0.01%	567
2013 Q2	$21K	Buy	+310	New	+$18.9K	0.01%	573

Other funds holding JAZZ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Smithfield Trust's JAZZ Position: Q2 2020 in Review

Smithfield Trust sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2020, closing a stake of 43 shares — an estimated $4K sold.

Smithfield Trust first reported a position in JAZZ in Q2 2013 and held it in 12 quarters. The position peaked at $27K in Q4 2013. 384 funds tracked by Wall St. Rank hold JAZZ as of Q2 2020.

Smithfield Trust reported no remaining Jazz Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
Smithfield Trust sold 43 Jazz Pharmaceuticals shares in Q2 2020, an estimated $4K.
Smithfield Trust first reported a position in Jazz Pharmaceuticals in Q2 2013 and held it in 12 quarters.
Smithfield Trust's Jazz Pharmaceuticals position peaked at $27K in Q4 2013.
384 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2020.

Based on Smithfield Trust's 13F filing for Q2 2020, filed 14 Aug 2020.